Michael Gibney

Michael Gibney
Michael Gibney

Michael Gibney is a former editor at FierceMarkets Life Sciences group.

Stories by Michael Gibney

New CRISPR/Cas9 delivery method could offer a clinical pathway

CRISPR/Cas9 gene editing is a rapidly developing technique that is thought to provide revolutionary new ways to manipulate genes for the treatment of a number of diseases. Delivering the CRISPR therapeutic in an efficient, safe and predictable way, though, has been difficult--to this end, researchers at Umass have created a means of administering the gene editor that could help send it to clinical trials.